GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cebpe
|
ENSRNOG00000014282 | CCAAT/enhancer binding protein epsilon |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cebpe | rn6_v1_chr15_-_33358138_33358138 | -0.04 | 4.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_148119857 | 101.56 |
ENSRNOT00000040325
|
LOC100361547
|
Cytochrome P450, family 2, subfamily c, polypeptide 7-like |
chr14_+_22251499 | 94.85 |
ENSRNOT00000087991
ENSRNOT00000002705 |
Ugt2a1
|
UDP glucuronosyltransferase 2 family, polypeptide A1 |
chr1_-_258875572 | 89.58 |
ENSRNOT00000093005
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13 |
chr15_+_57290849 | 87.59 |
ENSRNOT00000014909
|
Cpb2
|
carboxypeptidase B2 |
chr19_+_42097995 | 87.38 |
ENSRNOT00000020197
|
Hp
|
haptoglobin |
chr14_+_22517774 | 86.11 |
ENSRNOT00000047655
|
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chr1_+_147713892 | 75.21 |
ENSRNOT00000092985
ENSRNOT00000054742 ENSRNOT00000074103 |
Cyp2c6v1
|
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
chr4_-_161850875 | 73.06 |
ENSRNOT00000009467
|
Pzp
|
pregnancy-zone protein |
chr11_-_81639872 | 68.33 |
ENSRNOT00000047595
ENSRNOT00000090031 ENSRNOT00000081864 |
Hrg
|
histidine-rich glycoprotein |
chr3_-_127500709 | 64.68 |
ENSRNOT00000006330
|
Hao1
|
hydroxyacid oxidase 1 |
chr14_+_22375955 | 63.19 |
ENSRNOT00000063915
ENSRNOT00000034784 |
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chr3_+_159936856 | 63.04 |
ENSRNOT00000078703
|
Hnf4a
|
hepatocyte nuclear factor 4, alpha |
chr3_-_55587946 | 62.72 |
ENSRNOT00000075107
|
Abcb11
|
ATP binding cassette subfamily B member 11 |
chr1_-_258766881 | 60.69 |
ENSRNOT00000015801
|
Cyp2c12
|
cytochrome P450, family 2, subfamily c, polypeptide 12 |
chr11_-_81660395 | 56.03 |
ENSRNOT00000048739
|
Fetub
|
fetuin B |
chr2_+_150146234 | 55.00 |
ENSRNOT00000018761
|
Aadac
|
arylacetamide deacetylase |
chr11_-_81717521 | 54.79 |
ENSRNOT00000058422
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr4_+_65110746 | 54.24 |
ENSRNOT00000017675
|
Akr1d1
|
aldo-keto reductase family 1, member D1 |
chr1_+_64506735 | 53.75 |
ENSRNOT00000086331
|
Nlrp12
|
NLR family, pyrin domain containing 12 |
chr1_+_83711251 | 53.68 |
ENSRNOT00000028237
ENSRNOT00000092008 |
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr1_+_83653234 | 53.67 |
ENSRNOT00000085008
ENSRNOT00000084230 ENSRNOT00000090071 |
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr2_+_243550627 | 52.55 |
ENSRNOT00000085067
ENSRNOT00000083682 |
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr1_+_248428099 | 51.60 |
ENSRNOT00000050984
|
Mbl2
|
mannose binding lectin 2 |
chr6_-_127534247 | 50.53 |
ENSRNOT00000012500
|
Serpina6
|
serpin family A member 6 |
chr3_+_159902441 | 49.43 |
ENSRNOT00000089893
ENSRNOT00000011978 |
Hnf4a
|
hepatocyte nuclear factor 4, alpha |
chr14_+_22724399 | 49.09 |
ENSRNOT00000002724
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr9_+_95256627 | 48.85 |
ENSRNOT00000025291
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chrX_+_143097525 | 48.32 |
ENSRNOT00000004559
|
F9
|
coagulation factor IX |
chr11_-_81735592 | 48.16 |
ENSRNOT00000078203
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr4_-_50200328 | 48.11 |
ENSRNOT00000060530
|
Aass
|
aminoadipate-semialdehyde synthase |
chr1_-_224389389 | 47.30 |
ENSRNOT00000077408
ENSRNOT00000050010 |
UST4r
|
integral membrane transport protein UST4r |
chr2_+_181987217 | 45.33 |
ENSRNOT00000034521
|
Fgg
|
fibrinogen gamma chain |
chr1_+_229030233 | 44.73 |
ENSRNOT00000084503
|
Glyatl1
|
glycine-N-acyltransferase-like 1 |
chr13_+_91080341 | 44.23 |
ENSRNOT00000000058
|
Crp
|
C-reactive protein |
chr13_-_56693968 | 44.12 |
ENSRNOT00000060160
|
AABR07021096.1
|
|
chr1_+_148240504 | 43.90 |
ENSRNOT00000085373
|
LOC100361547
|
Cytochrome P450, family 2, subfamily c, polypeptide 7-like |
chr16_+_6970342 | 43.36 |
ENSRNOT00000061294
ENSRNOT00000048344 |
Itih4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr9_+_9721105 | 42.78 |
ENSRNOT00000073042
ENSRNOT00000075494 |
C3
|
complement C3 |
chr11_-_81444375 | 42.23 |
ENSRNOT00000058479
ENSRNOT00000078131 ENSRNOT00000080949 ENSRNOT00000080562 ENSRNOT00000084867 |
Kng1
|
kininogen 1 |
chr2_+_55775274 | 41.39 |
ENSRNOT00000018545
|
C9
|
complement C9 |
chr8_-_50531423 | 41.20 |
ENSRNOT00000090985
ENSRNOT00000074942 |
Apoc3
|
apolipoprotein C3 |
chr13_+_56598957 | 38.66 |
ENSRNOT00000016944
ENSRNOT00000080335 ENSRNOT00000089913 |
F13b
|
coagulation factor XIII B chain |
chr1_+_40086470 | 38.39 |
ENSRNOT00000021895
|
Iyd
|
iodotyrosine deiodinase |
chr4_-_154855098 | 38.09 |
ENSRNOT00000041957
|
LOC297568
|
alpha-1-inhibitor III |
chr5_-_134484839 | 37.36 |
ENSRNOT00000045571
ENSRNOT00000012681 |
Cyp4a2
|
cytochrome P450, family 4, subfamily a, polypeptide 2 |
chr1_-_258877045 | 37.12 |
ENSRNOT00000071633
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13 |
chr12_-_22194287 | 36.94 |
ENSRNOT00000082895
ENSRNOT00000001905 |
Tfr2
|
transferrin receptor 2 |
chr9_-_4978892 | 36.64 |
ENSRNOT00000015189
|
Sult1c3
|
sulfotransferase family 1C member 3 |
chr10_+_96639924 | 36.55 |
ENSRNOT00000004756
|
Apoh
|
apolipoprotein H |
chr16_+_50152008 | 35.86 |
ENSRNOT00000019237
|
Klkb1
|
kallikrein B1 |
chr1_+_229039889 | 35.73 |
ENSRNOT00000054800
|
Glyatl1
|
glycine-N-acyltransferase-like 1 |
chr1_-_224533219 | 35.33 |
ENSRNOT00000051289
|
Ust5r
|
integral membrane transport protein UST5r |
chr7_+_93975451 | 35.27 |
ENSRNOT00000011379
|
Colec10
|
collectin subfamily member 10 |
chr16_+_18690246 | 35.13 |
ENSRNOT00000081484
|
Mat1a
|
methionine adenosyltransferase 1A |
chr6_+_128050250 | 34.71 |
ENSRNOT00000077517
ENSRNOT00000013961 |
LOC500712
|
Ab1-233 |
chr6_-_128003418 | 34.60 |
ENSRNOT00000013896
|
Serpina3c
|
serine (or cysteine) proteinase inhibitor, clade A, member 3C |
chr5_-_119564846 | 34.47 |
ENSRNOT00000012977
|
Cyp2j4
|
cytochrome P450, family 2, subfamily j, polypeptide 4 |
chr11_-_66034573 | 34.17 |
ENSRNOT00000003645
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr7_-_123630045 | 33.70 |
ENSRNOT00000050002
|
Cyp2d1
|
cytochrome P450, family 2, subfamily d, polypeptide 1 |
chr7_-_3386522 | 33.52 |
ENSRNOT00000010760
|
Mettl7b
|
methyltransferase like 7B |
chr13_-_57080491 | 33.16 |
ENSRNOT00000017749
ENSRNOT00000086572 ENSRNOT00000060111 |
Cfh
|
complement factor H |
chr16_+_18690649 | 33.03 |
ENSRNOT00000015190
|
Mat1a
|
methionine adenosyltransferase 1A |
chr7_-_2677199 | 32.90 |
ENSRNOT00000043908
|
Apon
|
apolipoprotein N |
chr1_+_16910069 | 32.68 |
ENSRNOT00000020015
|
Aldh8a1
|
aldehyde dehydrogenase 8 family, member A1 |
chr14_-_19191863 | 32.57 |
ENSRNOT00000003921
|
Alb
|
albumin |
chr6_+_127946686 | 32.19 |
ENSRNOT00000082680
|
LOC500712
|
Ab1-233 |
chr13_-_80745347 | 32.11 |
ENSRNOT00000041908
|
Fmo1
|
flavin containing monooxygenase 1 |
chr12_+_19196611 | 31.89 |
ENSRNOT00000001801
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding |
chr9_-_79630452 | 31.82 |
ENSRNOT00000078125
ENSRNOT00000086044 ENSRNOT00000089283 |
Pecr
|
peroxisomal trans-2-enoyl-CoA reductase |
chr14_+_22937421 | 31.74 |
ENSRNOT00000065079
|
RGD1559459
|
similar to Expressed sequence AI788959 |
chr6_+_128046780 | 31.60 |
ENSRNOT00000078064
|
LOC500712
|
Ab1-233 |
chr14_-_19072677 | 30.98 |
ENSRNOT00000060548
|
LOC360919
|
similar to alpha-fetoprotein |
chr15_+_28028521 | 30.94 |
ENSRNOT00000089631
|
AC114343.1
|
|
chr19_-_57333433 | 30.74 |
ENSRNOT00000024917
|
Agt
|
angiotensinogen |
chr17_+_30556884 | 30.16 |
ENSRNOT00000080929
ENSRNOT00000022022 |
Eci2
|
enoyl-CoA delta isomerase 2 |
chr1_-_259287684 | 30.01 |
ENSRNOT00000054724
|
Cyp2c22
|
cytochrome P450, family 2, subfamily c, polypeptide 22 |
chr19_+_15081590 | 29.46 |
ENSRNOT00000024187
|
Ces1f
|
carboxylesterase 1F |
chr1_+_83744238 | 29.06 |
ENSRNOT00000028249
|
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr12_-_19114399 | 29.05 |
ENSRNOT00000073099
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9 |
chr2_-_264293010 | 28.92 |
ENSRNOT00000082532
ENSRNOT00000067843 |
LOC103691744
|
cystathionine gamma-lyase |
chr7_-_14435967 | 28.88 |
ENSRNOT00000074801
|
Pglyrp2
|
peptidoglycan recognition protein 2 |
chr7_-_123621102 | 28.41 |
ENSRNOT00000046024
|
Cyp2d5
|
cytochrome P450, family 2, subfamily d, polypeptide 5 |
chr14_+_22724070 | 28.27 |
ENSRNOT00000089471
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr16_+_54164431 | 27.86 |
ENSRNOT00000090763
|
Fgl1
|
fibrinogen-like 1 |
chr2_+_104744461 | 27.68 |
ENSRNOT00000016083
ENSRNOT00000082627 |
Cp
|
ceruloplasmin |
chr10_-_77512032 | 27.65 |
ENSRNOT00000003295
|
Pctp
|
phosphatidylcholine transfer protein |
chr6_-_104631355 | 27.65 |
ENSRNOT00000007825
|
Slc10a1
|
solute carrier family 10 member 1 |
chr7_-_71226150 | 26.93 |
ENSRNOT00000005875
|
RGD1561812
|
similar to Retinol dehydrogenase type II (RODH II) (29 k-protein) |
chr5_+_60528997 | 26.80 |
ENSRNOT00000051445
|
Grhpr
|
glyoxylate and hydroxypyruvate reductase |
chr16_+_10267482 | 26.36 |
ENSRNOT00000085255
|
Gdf2
|
growth differentiation factor 2 |
chr9_-_4945352 | 26.33 |
ENSRNOT00000082530
|
Sult1c3
|
sulfotransferase family 1C member 3 |
chr17_-_69460321 | 26.20 |
ENSRNOT00000058367
|
Akr1c1
|
aldo-keto reductase family 1, member C1 |
chr6_+_80188943 | 25.76 |
ENSRNOT00000059335
|
Mia2
|
melanoma inhibitory activity 2 |
chr15_-_45524582 | 25.38 |
ENSRNOT00000081912
|
Gucy1b2
|
guanylate cyclase 1 soluble subunit beta 2 |
chr2_+_54466280 | 25.38 |
ENSRNOT00000033112
|
C6
|
complement C6 |
chr1_-_76722965 | 25.26 |
ENSRNOT00000052129
|
LOC100912485
|
alcohol sulfotransferase-like |
chr6_-_7058314 | 25.15 |
ENSRNOT00000045996
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr4_-_70659252 | 25.00 |
ENSRNOT00000048049
|
Try10
|
trypsin 10 |
chr16_+_50179458 | 24.51 |
ENSRNOT00000041946
|
F11
|
coagulation factor XI |
chr6_-_47890033 | 24.46 |
ENSRNOT00000011290
|
Colec11
|
collectin sub-family member 11 |
chr9_+_46962288 | 24.15 |
ENSRNOT00000082146
|
Il1r1
|
interleukin 1 receptor type 1 |
chr17_-_69827112 | 24.02 |
ENSRNOT00000023835
|
Akr1c14
|
aldo-keto reductase family 1, member C14 |
chr11_+_74057361 | 23.98 |
ENSRNOT00000048746
|
Cpn2
|
carboxypeptidase N subunit 2 |
chr17_+_8489266 | 23.90 |
ENSRNOT00000016252
|
Lect2
|
leukocyte cell-derived chemotaxin 2 |
chr20_-_30947484 | 23.56 |
ENSRNOT00000065614
|
Pald1
|
phosphatase domain containing, paladin 1 |
chr9_-_19880346 | 23.53 |
ENSRNOT00000014051
|
Cyp39a1
|
cytochrome P450, family 39, subfamily a, polypeptide 1 |
chr15_+_28018040 | 23.39 |
ENSRNOT00000041495
|
Rnase4
|
ribonuclease A family member 4 |
chr2_-_164684985 | 22.89 |
ENSRNOT00000057504
|
Rarres1
|
retinoic acid receptor responder 1 |
chr11_-_87921679 | 22.78 |
ENSRNOT00000084973
|
Serpind1
|
serpin family D member 1 |
chr10_+_64952119 | 22.47 |
ENSRNOT00000012154
|
Pipox
|
pipecolic acid and sarcosine oxidase |
chr4_+_109497962 | 21.88 |
ENSRNOT00000057869
|
Reg1a
|
regenerating family member 1 alpha |
chr9_+_95161157 | 21.73 |
ENSRNOT00000071200
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr4_+_65112944 | 21.68 |
ENSRNOT00000083672
|
Akr1d1
|
aldo-keto reductase family 1, member D1 |
chr14_-_86190659 | 21.57 |
ENSRNOT00000086474
|
Gck
|
glucokinase |
chr6_+_107550904 | 21.38 |
ENSRNOT00000013760
|
Acot5
|
acyl-CoA thioesterase 5 |
chr20_+_40769586 | 21.16 |
ENSRNOT00000001079
|
Fabp7
|
fatty acid binding protein 7 |
chr15_+_27875911 | 21.09 |
ENSRNOT00000013582
|
Pnp
|
purine nucleoside phosphorylase |
chr1_-_222167447 | 21.06 |
ENSRNOT00000028687
|
Prdx5
|
peroxiredoxin 5 |
chr14_+_7113544 | 21.01 |
ENSRNOT00000038188
|
Hsd17b13
|
hydroxysteroid (17-beta) dehydrogenase 13 |
chr10_-_38774449 | 20.85 |
ENSRNOT00000049820
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr7_-_123655896 | 20.81 |
ENSRNOT00000012413
|
Cyp2d2
|
cytochrome P450, family 2, subfamily d, polypeptide 2 |
chr4_-_23135354 | 20.76 |
ENSRNOT00000011432
|
Steap4
|
STEAP4 metalloreductase |
chr17_-_69404323 | 20.64 |
ENSRNOT00000051342
ENSRNOT00000066282 |
Akr1c2
|
aldo-keto reductase family 1, member C2 |
chr20_-_4542073 | 20.48 |
ENSRNOT00000000477
|
Cfb
|
complement factor B |
chr4_+_98457810 | 20.40 |
ENSRNOT00000074175
|
AABR07060872.1
|
|
chr5_+_127770570 | 20.07 |
ENSRNOT00000047653
|
Echdc2
|
enoyl CoA hydratase domain containing 2 |
chr6_-_129010271 | 19.94 |
ENSRNOT00000075378
|
Serpina10
|
serpin family A member 10 |
chr13_+_78812394 | 19.94 |
ENSRNOT00000076043
|
Serpinc1
|
serpin family C member 1 |
chr4_-_157155609 | 19.93 |
ENSRNOT00000016330
|
C1s
|
complement C1s |
chr9_+_81656116 | 19.69 |
ENSRNOT00000083421
|
Slc11a1
|
solute carrier family 11 member 1 |
chr7_-_129970550 | 19.66 |
ENSRNOT00000055879
|
Mlc1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
chr19_+_15094309 | 19.61 |
ENSRNOT00000083500
|
Ces1f
|
carboxylesterase 1F |
chr19_+_15081158 | 19.52 |
ENSRNOT00000074070
|
Ces1f
|
carboxylesterase 1F |
chr9_+_95274707 | 19.51 |
ENSRNOT00000045163
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr14_-_44613904 | 19.50 |
ENSRNOT00000003811
|
Klb
|
klotho beta |
chr8_+_116857684 | 19.45 |
ENSRNOT00000026711
|
Mst1
|
macrophage stimulating 1 |
chr8_-_111721303 | 19.41 |
ENSRNOT00000045628
ENSRNOT00000012725 |
Tf
|
transferrin |
chr5_-_59553416 | 19.27 |
ENSRNOT00000090490
|
Gne
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
chr14_+_2050483 | 18.78 |
ENSRNOT00000000047
|
Slc26a1
|
solute carrier family 26 member 1 |
chr13_+_103396314 | 18.76 |
ENSRNOT00000049499
|
Slc30a10
|
solute carrier family 30, member 10 |
chr14_-_19132208 | 18.32 |
ENSRNOT00000060535
|
Afm
|
afamin |
chrX_+_25016401 | 18.28 |
ENSRNOT00000059270
|
Clcn4
|
chloride voltage-gated channel 4 |
chr3_+_5519990 | 18.27 |
ENSRNOT00000070873
ENSRNOT00000007640 |
Adamts13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13 |
chr5_+_61425746 | 18.23 |
ENSRNOT00000064113
|
RGD1305807
|
hypothetical LOC298077 |
chr17_+_22620721 | 18.04 |
ENSRNOT00000019478
|
Adtrp
|
androgen-dependent TFPI-regulating protein |
chrX_+_152933069 | 17.81 |
ENSRNOT00000091154
|
Nsdhl
|
NAD(P) dependent steroid dehydrogenase-like |
chr17_+_22619891 | 17.76 |
ENSRNOT00000060403
|
Adtrp
|
androgen-dependent TFPI-regulating protein |
chr12_+_18679789 | 17.60 |
ENSRNOT00000001863
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9 |
chr3_-_48372583 | 17.50 |
ENSRNOT00000040482
ENSRNOT00000077788 ENSRNOT00000085426 |
Dpp4
|
dipeptidylpeptidase 4 |
chr11_+_65022100 | 17.46 |
ENSRNOT00000003934
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr13_-_111972603 | 17.35 |
ENSRNOT00000007870
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr2_+_222214885 | 17.35 |
ENSRNOT00000055723
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr17_+_69468427 | 17.31 |
ENSRNOT00000058413
|
RGD1564865
|
similar to 20-alpha-hydroxysteroid dehydrogenase |
chr4_-_176679815 | 17.14 |
ENSRNOT00000090122
|
Gys2
|
glycogen synthase 2 |
chr2_-_233743866 | 17.10 |
ENSRNOT00000087062
|
Enpep
|
glutamyl aminopeptidase |
chr19_+_15339152 | 16.97 |
ENSRNOT00000060929
|
Ces1a
|
carboxylesterase 1A |
chr7_-_27552078 | 16.88 |
ENSRNOT00000059538
|
Stab2
|
stabilin 2 |
chr18_-_35071619 | 16.83 |
ENSRNOT00000075695
|
LOC100911558
|
serine protease inhibitor Kazal-type 3-like |
chr13_+_83073544 | 16.61 |
ENSRNOT00000066119
ENSRNOT00000079796 ENSRNOT00000077070 |
Dpt
|
dermatopontin |
chr14_-_80973456 | 16.50 |
ENSRNOT00000013257
|
Hgfac
|
HGF activator |
chr3_+_54253949 | 16.49 |
ENSRNOT00000010018
|
B3galt1
|
Beta-1,3-galactosyltransferase 1 |
chr9_+_95202632 | 16.44 |
ENSRNOT00000025652
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr7_+_28412198 | 16.38 |
ENSRNOT00000081822
ENSRNOT00000038780 ENSRNOT00000005995 |
Igf1
|
insulin-like growth factor 1 |
chr14_-_19159923 | 15.91 |
ENSRNOT00000003879
|
Afp
|
alpha-fetoprotein |
chr1_+_167937026 | 15.83 |
ENSRNOT00000020655
|
Olr57
|
olfactory receptor 57 |
chr17_+_76002275 | 15.82 |
ENSRNOT00000092665
ENSRNOT00000086701 |
Echdc3
|
enoyl CoA hydratase domain containing 3 |
chr1_+_166428761 | 15.71 |
ENSRNOT00000085555
|
Stard10
|
StAR-related lipid transfer domain containing 10 |
chr7_+_70980422 | 15.68 |
ENSRNOT00000077912
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr8_+_117117430 | 15.58 |
ENSRNOT00000073247
|
Gpx1
|
glutathione peroxidase 1 |
chr4_+_70776046 | 15.52 |
ENSRNOT00000040403
|
Prss1
|
protease, serine 1 |
chr9_+_4107246 | 15.42 |
ENSRNOT00000078212
|
AABR07066160.1
|
|
chr10_+_64737022 | 15.17 |
ENSRNOT00000017071
ENSRNOT00000093232 ENSRNOT00000017042 ENSRNOT00000093244 |
Lgals9
|
galectin 9 |
chr4_+_157126935 | 15.12 |
ENSRNOT00000056051
|
C1r
|
complement C1r |
chr13_+_91481461 | 15.07 |
ENSRNOT00000012103
|
Olr1576
|
olfactory receptor 1576 |
chr20_-_4070721 | 15.04 |
ENSRNOT00000000523
|
RT1-Ba
|
RT1 class II, locus Ba |
chr4_-_30556814 | 15.02 |
ENSRNOT00000012760
|
Pdk4
|
pyruvate dehydrogenase kinase 4 |
chr2_-_181905300 | 14.95 |
ENSRNOT00000035411
|
Lrat
|
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
chr7_+_101069104 | 14.94 |
ENSRNOT00000056894
|
AABR07058124.2
|
|
chr11_-_80981415 | 14.84 |
ENSRNOT00000002499
ENSRNOT00000002496 |
St6gal1
|
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
chr5_-_77749613 | 14.80 |
ENSRNOT00000075988
|
Mup5
|
major urinary protein 5 |
chr1_+_282638017 | 14.68 |
ENSRNOT00000079722
ENSRNOT00000082254 |
Ces2c
|
carboxylesterase 2C |
chr7_+_71057911 | 14.61 |
ENSRNOT00000037218
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr3_-_76518601 | 14.52 |
ENSRNOT00000071021
|
Olr623
|
olfactory receptor 623 |
chr1_+_282694906 | 14.39 |
ENSRNOT00000074303
|
Ces2c
|
carboxylesterase 2C |
chr13_+_83073866 | 14.38 |
ENSRNOT00000075996
|
Dpt
|
dermatopontin |
chr5_+_135536413 | 14.36 |
ENSRNOT00000023132
|
Prdx1
|
peroxiredoxin 1 |
chr4_-_123557501 | 14.13 |
ENSRNOT00000075042
ENSRNOT00000085966 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr10_+_104368247 | 14.13 |
ENSRNOT00000006519
|
Llgl2
|
LLGL2, scribble cell polarity complex component |
chr9_+_81968332 | 14.08 |
ENSRNOT00000023152
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr4_+_70755795 | 14.04 |
ENSRNOT00000043527
|
LOC683849
|
similar to Anionic trypsin II precursor (Pretrypsinogen II) |
chr14_+_84274550 | 13.95 |
ENSRNOT00000006053
ENSRNOT00000087383 |
Sec14l4
|
SEC14-like lipid binding 4 |
chr7_+_28414350 | 13.92 |
ENSRNOT00000085680
|
Igf1
|
insulin-like growth factor 1 |
chr1_-_251338358 | 13.88 |
ENSRNOT00000002054
|
Cyp2b15
|
cytochrome P450, family 2, subfamily b, polypeptide 15 |
chr15_-_19733967 | 13.86 |
ENSRNOT00000012036
|
Gnpnat1
|
glucosamine-phosphate N-acetyltransferase 1 |
chr10_-_98390384 | 13.73 |
ENSRNOT00000065947
|
Abca8a
|
ATP-binding cassette, subfamily A (ABC1), member 8a |
chr1_-_189181901 | 13.72 |
ENSRNOT00000092022
|
Gp2
|
glycoprotein 2 |
chr17_+_79749747 | 13.70 |
ENSRNOT00000081743
|
AABR07028665.1
|
|
chr5_+_154294806 | 13.58 |
ENSRNOT00000012853
|
Hmgcl
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase |
chr5_+_160306727 | 13.57 |
ENSRNOT00000016648
|
Agmat
|
agmatinase |
chr13_-_99287887 | 13.53 |
ENSRNOT00000004780
|
Ephx1
|
epoxide hydrolase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
39.4 | 118.3 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
32.0 | 128.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
29.1 | 87.4 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
28.1 | 112.5 | GO:0042977 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
22.8 | 68.3 | GO:0097037 | heme export(GO:0097037) |
22.5 | 607.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
18.1 | 54.4 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
17.9 | 53.8 | GO:0008592 | regulation of Toll signaling pathway(GO:0008592) negative regulation of Toll signaling pathway(GO:0045751) |
17.6 | 70.6 | GO:0019477 | lysine catabolic process(GO:0006554) L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
17.5 | 52.6 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
16.2 | 64.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
15.9 | 206.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
15.1 | 60.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
14.1 | 56.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
13.7 | 41.2 | GO:0010982 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) regulation of high-density lipoprotein particle clearance(GO:0010982) |
13.6 | 68.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
11.7 | 23.5 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
11.7 | 46.7 | GO:0002933 | lipid hydroxylation(GO:0002933) alkaloid catabolic process(GO:0009822) |
11.4 | 34.2 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
10.6 | 31.8 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
10.5 | 41.9 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
9.7 | 87.4 | GO:0046618 | drug export(GO:0046618) |
9.6 | 28.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
9.3 | 28.0 | GO:1990743 | protein sialylation(GO:1990743) |
9.3 | 9.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
9.0 | 63.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
8.6 | 60.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
8.2 | 32.9 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
7.9 | 102.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
7.6 | 30.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
7.4 | 44.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
7.3 | 21.9 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
7.2 | 35.9 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
7.1 | 21.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
7.1 | 28.5 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
7.0 | 21.1 | GO:0034418 | nicotinamide riboside catabolic process(GO:0006738) urate biosynthetic process(GO:0034418) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
6.9 | 55.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
6.7 | 6.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
6.4 | 19.3 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) |
6.3 | 18.8 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
6.2 | 62.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
6.2 | 61.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
6.1 | 18.2 | GO:0046864 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
5.8 | 17.5 | GO:0061744 | motor behavior(GO:0061744) |
5.8 | 17.3 | GO:0046127 | thymidine catabolic process(GO:0006214) pyrimidine deoxyribonucleoside catabolic process(GO:0046127) |
5.8 | 17.3 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
5.7 | 45.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
5.6 | 72.6 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
5.5 | 22.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
5.5 | 27.7 | GO:0015679 | plasma membrane copper ion transport(GO:0015679) |
5.4 | 32.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) response to platinum ion(GO:0070541) |
5.3 | 47.5 | GO:0015747 | urate transport(GO:0015747) |
5.2 | 15.6 | GO:0009609 | response to symbiotic bacterium(GO:0009609) |
4.7 | 108.6 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
4.7 | 14.1 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
4.7 | 14.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
4.6 | 23.0 | GO:0002003 | angiotensin maturation(GO:0002003) |
4.5 | 13.4 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
4.3 | 8.7 | GO:0070839 | divalent metal ion export(GO:0070839) |
4.3 | 21.6 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
4.3 | 25.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
4.2 | 12.5 | GO:0014016 | neuroblast differentiation(GO:0014016) |
4.0 | 32.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
3.8 | 15.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
3.6 | 10.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
3.5 | 14.1 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
3.4 | 6.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
3.4 | 13.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.2 | 16.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
3.1 | 9.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
3.1 | 12.5 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
3.1 | 6.1 | GO:0042223 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
3.0 | 32.7 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
2.9 | 5.7 | GO:0009608 | response to symbiont(GO:0009608) |
2.9 | 11.5 | GO:0035772 | interleukin-13-mediated signaling pathway(GO:0035772) |
2.8 | 19.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
2.7 | 8.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
2.7 | 13.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
2.7 | 8.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.7 | 8.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.6 | 66.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
2.6 | 10.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
2.6 | 7.8 | GO:2000978 | gastrin-induced gastric acid secretion(GO:0001698) positive regulation of actin filament-based movement(GO:1903116) negative regulation of forebrain neuron differentiation(GO:2000978) |
2.6 | 20.8 | GO:0015677 | copper ion import(GO:0015677) |
2.6 | 25.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
2.6 | 23.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.5 | 7.6 | GO:0048749 | compound eye development(GO:0048749) |
2.5 | 7.6 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
2.5 | 17.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
2.5 | 35.4 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
2.5 | 67.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
2.5 | 57.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
2.4 | 7.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
2.4 | 7.3 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
2.4 | 16.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.4 | 21.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
2.3 | 7.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
2.3 | 46.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
2.3 | 13.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
2.2 | 6.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
2.2 | 2.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
2.2 | 10.9 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
2.2 | 10.8 | GO:0009758 | carbohydrate utilization(GO:0009758) |
2.2 | 12.9 | GO:0008050 | female courtship behavior(GO:0008050) |
2.1 | 8.5 | GO:1990375 | baculum development(GO:1990375) |
2.1 | 10.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
2.1 | 17.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.1 | 10.4 | GO:0009115 | xanthine catabolic process(GO:0009115) |
2.1 | 6.2 | GO:2000502 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) negative regulation of natural killer cell chemotaxis(GO:2000502) |
2.0 | 5.9 | GO:2000424 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
2.0 | 5.9 | GO:0002462 | tolerance induction to nonself antigen(GO:0002462) |
2.0 | 2.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.9 | 15.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.8 | 86.9 | GO:0006953 | acute-phase response(GO:0006953) |
1.8 | 7.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.7 | 10.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.7 | 5.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.7 | 6.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.7 | 11.6 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
1.7 | 48.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
1.6 | 6.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.6 | 4.9 | GO:0046968 | cytosol to ER transport(GO:0046967) peptide antigen transport(GO:0046968) |
1.6 | 4.9 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
1.6 | 8.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.6 | 4.8 | GO:1901423 | response to benzene(GO:1901423) |
1.6 | 6.4 | GO:1902896 | terminal web assembly(GO:1902896) |
1.6 | 11.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
1.6 | 8.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.6 | 3.2 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
1.6 | 4.7 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
1.5 | 26.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.5 | 4.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.5 | 59.5 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
1.5 | 4.5 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.5 | 13.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.5 | 10.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.4 | 5.6 | GO:0019516 | lactate oxidation(GO:0019516) |
1.4 | 7.0 | GO:0001757 | somite specification(GO:0001757) |
1.4 | 8.3 | GO:0010041 | response to iron(III) ion(GO:0010041) response to anoxia(GO:0034059) |
1.4 | 5.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.4 | 22.1 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
1.4 | 2.7 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.4 | 12.3 | GO:0034312 | diol biosynthetic process(GO:0034312) |
1.4 | 6.8 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.3 | 4.0 | GO:0006574 | valine catabolic process(GO:0006574) |
1.3 | 5.3 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
1.3 | 5.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
1.3 | 5.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.2 | 13.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.2 | 67.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
1.2 | 19.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.2 | 29.1 | GO:0042168 | heme metabolic process(GO:0042168) |
1.2 | 10.7 | GO:0006983 | ER overload response(GO:0006983) |
1.2 | 7.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
1.2 | 7.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.1 | 3.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.1 | 15.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.1 | 15.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.1 | 3.2 | GO:0035565 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
1.0 | 3.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.0 | 8.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.0 | 7.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) negative regulation of nuclease activity(GO:0032074) |
1.0 | 3.1 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.0 | 2.0 | GO:0072717 | response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
1.0 | 10.2 | GO:0006465 | signal peptide processing(GO:0006465) |
1.0 | 30.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
1.0 | 15.1 | GO:0006956 | complement activation(GO:0006956) |
1.0 | 8.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.0 | 6.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.0 | 3.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.0 | 3.9 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
1.0 | 9.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.0 | 15.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
1.0 | 12.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
1.0 | 1.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.9 | 54.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.9 | 4.7 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.9 | 27.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.9 | 5.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.9 | 4.4 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.9 | 8.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.9 | 2.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.9 | 6.9 | GO:0015866 | ADP transport(GO:0015866) ATP transport(GO:0015867) |
0.9 | 5.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.9 | 14.6 | GO:1902358 | oxalate transport(GO:0019532) sulfate transmembrane transport(GO:1902358) |
0.9 | 6.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.9 | 11.9 | GO:0042407 | cristae formation(GO:0042407) |
0.8 | 7.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.8 | 5.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.8 | 4.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) generation of ovulation cycle rhythm(GO:0060112) |
0.8 | 3.3 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.8 | 2.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.8 | 1049.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.8 | 7.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.8 | 6.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.8 | 17.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.8 | 4.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.8 | 5.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.8 | 5.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.8 | 11.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.8 | 6.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.8 | 14.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.8 | 3.1 | GO:0019042 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.8 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 14.9 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.7 | 0.7 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.7 | 5.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.7 | 2.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.7 | 2.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.7 | 11.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.7 | 12.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.7 | 9.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 2.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.7 | 3.6 | GO:0050916 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) sensory perception of sweet taste(GO:0050916) |
0.7 | 6.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 2.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.7 | 2.0 | GO:0032365 | intracellular lipid transport(GO:0032365) intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.7 | 10.2 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.7 | 6.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.7 | 2.0 | GO:0072679 | thymocyte migration(GO:0072679) |
0.7 | 2.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.7 | 2.7 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.7 | 2.0 | GO:0036258 | multivesicular body assembly(GO:0036258) negative regulation of exosomal secretion(GO:1903542) |
0.7 | 2.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.7 | 20.9 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.6 | 9.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.6 | 14.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.6 | 1.9 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.6 | 2.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.6 | 3.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.6 | 4.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 3.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 2.4 | GO:0036166 | DNA methylation on cytosine within a CG sequence(GO:0010424) phenotypic switching(GO:0036166) |
0.6 | 4.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.6 | 28.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.6 | 1.8 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 2.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.6 | 20.1 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.6 | 2.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.6 | 1.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 5.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.6 | 6.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 2.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 3.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 6.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.6 | 4.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 5.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.6 | 1.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 13.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.5 | 3.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.5 | 3.1 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 4.6 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.5 | 1.5 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.5 | 4.5 | GO:0045059 | positive regulation of T cell differentiation in thymus(GO:0033089) positive thymic T cell selection(GO:0045059) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 17.5 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 7.5 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.5 | 75.6 | GO:0007596 | blood coagulation(GO:0007596) |
0.5 | 12.3 | GO:0097502 | mannosylation(GO:0097502) |
0.5 | 7.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 12.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.5 | 3.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.5 | 4.7 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.5 | 30.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.5 | 1.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 3.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 1.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.5 | 4.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.5 | 2.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 1.3 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.4 | 1.3 | GO:0033197 | response to vitamin E(GO:0033197) |
0.4 | 10.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 4.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.4 | 15.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 1.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 3.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 2.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.4 | 1.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 0.8 | GO:0046687 | response to chromate(GO:0046687) |
0.4 | 1.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 2.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.4 | 3.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 2.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 3.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.4 | 2.3 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.4 | 4.9 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.4 | 26.8 | GO:0043648 | dicarboxylic acid metabolic process(GO:0043648) |
0.4 | 0.8 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.4 | 6.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 0.7 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.4 | 2.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.5 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.4 | 4.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 1.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.4 | 1.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 5.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 3.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 17.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 27.3 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.3 | 2.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.3 | 1.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 3.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 2.3 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.6 | GO:1904009 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
0.3 | 5.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 7.6 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 4.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.9 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.3 | 0.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 0.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.3 | 3.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 2.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 5.8 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 2.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 2.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 2.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 3.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.3 | 24.8 | GO:0007586 | digestion(GO:0007586) |
0.3 | 0.8 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.3 | 2.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 2.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.3 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 5.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 2.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 2.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 2.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 1.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.2 | 1.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 0.7 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.2 | 4.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 1.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.9 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 1.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 2.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 1.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 1.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 2.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 3.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 3.4 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.2 | 1.2 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 3.8 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 2.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 5.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.6 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 1.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 4.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.2 | 1.1 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.2 | 4.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 2.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 3.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.2 | 6.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 3.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.2 | 2.7 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 6.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 1.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.2 | 4.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 1.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 4.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 24.4 | GO:0006790 | sulfur compound metabolic process(GO:0006790) |
0.2 | 10.3 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 2.6 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 1.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.1 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 1.2 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) ureter development(GO:0072189) |
0.1 | 23.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.6 | GO:0048318 | protein O-linked glycosylation via serine(GO:0018242) axial mesoderm development(GO:0048318) |
0.1 | 0.8 | GO:0035745 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 1.6 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.4 | GO:0046886 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 4.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 13.2 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 3.6 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 0.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 1.7 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 1.9 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 2.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.4 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.4 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.5 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 1.0 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.7 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.1 | 0.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.2 | GO:0018065 | protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
0.1 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.1 | GO:0009189 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 1.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 2.7 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.2 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0032197 | transposition, RNA-mediated(GO:0032197) |
0.0 | 0.5 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.0 | 1.8 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.3 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 14.5 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.5 | GO:1903557 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.8 | 87.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
17.1 | 68.3 | GO:0061474 | phagolysosome membrane(GO:0061474) |
10.6 | 63.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
10.3 | 41.4 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
7.9 | 103.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
7.8 | 23.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
6.9 | 41.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
6.1 | 30.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
5.7 | 45.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
5.2 | 36.5 | GO:0042627 | chylomicron(GO:0042627) |
5.1 | 25.4 | GO:0005579 | membrane attack complex(GO:0005579) |
4.3 | 12.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
4.3 | 468.8 | GO:0072562 | blood microparticle(GO:0072562) |
3.6 | 71.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
3.1 | 9.4 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
3.1 | 15.6 | GO:0097413 | Lewy body(GO:0097413) |
3.1 | 28.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.8 | 13.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
2.4 | 38.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.1 | 6.2 | GO:0071942 | XPC complex(GO:0071942) |
2.0 | 5.9 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
1.7 | 7.0 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
1.7 | 11.9 | GO:0061617 | MICOS complex(GO:0061617) |
1.7 | 10.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.6 | 8.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.6 | 7.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.5 | 6.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.5 | 107.2 | GO:0005581 | collagen trimer(GO:0005581) |
1.4 | 92.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.4 | 6.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.3 | 17.1 | GO:0031983 | vesicle lumen(GO:0031983) |
1.3 | 3.9 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
1.3 | 20.7 | GO:0045180 | basal cortex(GO:0045180) |
1.3 | 24.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.3 | 21.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.2 | 970.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
1.2 | 4.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 9.7 | GO:0042587 | glycogen granule(GO:0042587) |
1.1 | 6.4 | GO:1990357 | terminal web(GO:1990357) |
1.1 | 25.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.1 | 9.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.0 | 9.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.0 | 138.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.0 | 17.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
1.0 | 3.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.9 | 2.8 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.9 | 9.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.9 | 6.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 7.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.8 | 4.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 2.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.8 | 3.1 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.8 | 10.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.7 | 4.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 1.4 | GO:0098576 | extrinsic component of Golgi membrane(GO:0090498) lumenal side of membrane(GO:0098576) |
0.7 | 3.6 | GO:1903767 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
0.7 | 6.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.7 | 2.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.7 | 33.0 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.7 | 9.9 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.6 | 5.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 18.0 | GO:0008305 | integrin complex(GO:0008305) |
0.6 | 2.5 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.6 | 25.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.6 | 1.8 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.6 | 20.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.6 | 8.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.6 | 2.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 2.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 7.0 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.5 | 691.4 | GO:0005615 | extracellular space(GO:0005615) |
0.5 | 6.6 | GO:0000801 | central element(GO:0000801) |
0.5 | 4.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.5 | 4.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 31.3 | GO:0045095 | keratin filament(GO:0045095) |
0.5 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.5 | 12.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.5 | 22.0 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 5.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 18.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 16.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.4 | 1.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 42.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 5.3 | GO:0045259 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.4 | 10.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 8.7 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 1.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 1.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 2.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 62.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 1.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 2.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 22.1 | GO:0005901 | caveola(GO:0005901) |
0.3 | 4.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 3.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.3 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 3.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 4.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 1.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 2.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 48.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 5.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 1.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 210.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 3.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.1 | GO:0070449 | elongin complex(GO:0070449) |
0.2 | 2.7 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 7.8 | GO:0005844 | polysome(GO:0005844) |
0.2 | 1.2 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 0.9 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 1.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 2.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 43.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 2.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 3.9 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 2.0 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 11.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 11.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 2.7 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 5.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 5.8 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 2.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 3.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 1.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 227.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.0 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 63.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 1.0 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.8 | 83.5 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
25.7 | 102.9 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
23.9 | 71.8 | GO:0008405 | arachidonic acid 11,12-epoxygenase activity(GO:0008405) |
23.6 | 70.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
22.7 | 68.2 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
21.2 | 572.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
16.2 | 64.7 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) |
15.7 | 63.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
14.8 | 459.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
14.6 | 73.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
14.3 | 42.8 | GO:0031714 | C5a anaphylatoxin chemotactic receptor binding(GO:0031714) |
13.7 | 41.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
13.4 | 80.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
12.2 | 36.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
11.4 | 34.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
10.7 | 75.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
10.3 | 51.6 | GO:0005534 | galactose binding(GO:0005534) |
9.8 | 118.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
8.9 | 35.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
8.8 | 52.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
8.2 | 24.6 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
8.2 | 90.3 | GO:0001846 | opsonin binding(GO:0001846) |
8.0 | 31.8 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
7.5 | 30.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
7.3 | 29.1 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
7.1 | 114.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
7.1 | 28.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
7.0 | 21.1 | GO:0002060 | purine nucleobase binding(GO:0002060) purine-nucleoside phosphorylase activity(GO:0004731) |
7.0 | 28.0 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
6.6 | 26.3 | GO:0008265 | Mo-molybdopterin cofactor sulfurase activity(GO:0008265) |
6.4 | 19.3 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
6.3 | 12.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
5.8 | 17.3 | GO:0004159 | dihydrouracil dehydrogenase (NAD+) activity(GO:0004159) dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113) |
5.8 | 17.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
5.7 | 141.5 | GO:0070330 | aromatase activity(GO:0070330) |
5.6 | 22.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
5.2 | 25.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
4.8 | 47.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
4.7 | 32.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
4.6 | 27.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
4.6 | 27.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
4.3 | 51.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
4.2 | 12.5 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
4.2 | 12.5 | GO:0008458 | carnitine O-octanoyltransferase activity(GO:0008458) O-octanoyltransferase activity(GO:0016414) |
3.9 | 23.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
3.9 | 34.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.8 | 15.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
3.7 | 22.0 | GO:0048030 | disaccharide binding(GO:0048030) |
3.6 | 10.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
3.6 | 21.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.5 | 10.6 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
3.5 | 20.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
3.4 | 24.0 | GO:0004064 | arylesterase activity(GO:0004064) |
3.4 | 13.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
3.4 | 10.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
3.4 | 36.9 | GO:0039706 | co-receptor binding(GO:0039706) |
3.4 | 80.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
3.3 | 13.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
3.3 | 13.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
3.1 | 9.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
3.1 | 62.6 | GO:0019825 | oxygen binding(GO:0019825) |
3.1 | 37.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
3.1 | 12.4 | GO:0055100 | adiponectin binding(GO:0055100) |
3.1 | 30.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
3.0 | 17.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
3.0 | 5.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
2.9 | 8.7 | GO:0001847 | opsonin receptor activity(GO:0001847) |
2.9 | 57.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
2.8 | 31.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
2.8 | 55.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
2.7 | 13.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.7 | 8.1 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.7 | 26.8 | GO:0070402 | NADPH binding(GO:0070402) |
2.7 | 26.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
2.7 | 5.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
2.7 | 13.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.6 | 49.0 | GO:0005537 | mannose binding(GO:0005537) |
2.6 | 38.4 | GO:0010181 | FMN binding(GO:0010181) |
2.5 | 7.6 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
2.5 | 7.6 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
2.5 | 279.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.5 | 29.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.5 | 34.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
2.5 | 17.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.5 | 12.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
2.4 | 7.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
2.4 | 7.3 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
2.3 | 9.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.2 | 22.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
2.1 | 6.4 | GO:0004956 | prostaglandin D receptor activity(GO:0004956) |
2.1 | 16.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
2.0 | 10.1 | GO:0032052 | bile acid binding(GO:0032052) |
2.0 | 8.0 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
2.0 | 21.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.9 | 5.6 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.8 | 12.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.8 | 39.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.8 | 5.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.7 | 3.4 | GO:0019767 | IgE receptor activity(GO:0019767) |
1.7 | 8.5 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
1.7 | 5.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.6 | 4.9 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
1.6 | 19.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.6 | 14.5 | GO:0019841 | retinol binding(GO:0019841) |
1.6 | 4.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.6 | 3.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.6 | 4.7 | GO:0042806 | fucose binding(GO:0042806) |
1.6 | 7.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.6 | 6.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.5 | 5.9 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
1.4 | 5.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.4 | 34.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.4 | 38.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.4 | 9.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.4 | 5.5 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
1.4 | 17.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.3 | 6.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.3 | 9.1 | GO:0045340 | mercury ion binding(GO:0045340) |
1.3 | 14.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
1.3 | 3.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.3 | 10.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.2 | 17.4 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.2 | 10.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.2 | 6.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.2 | 6.2 | GO:0035473 | lipase binding(GO:0035473) |
1.2 | 5.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.2 | 5.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.2 | 245.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.1 | 95.9 | GO:0003823 | antigen binding(GO:0003823) |
1.1 | 453.2 | GO:0005549 | odorant binding(GO:0005549) |
1.1 | 7.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.1 | 4.4 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) TFIIIC-class transcription factor binding(GO:0001156) |
1.1 | 11.9 | GO:0070513 | death domain binding(GO:0070513) |
1.0 | 26.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.0 | 13.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.0 | 30.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.0 | 4.0 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
1.0 | 14.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.0 | 2.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.0 | 2.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.0 | 2.9 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.0 | 4.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.9 | 10.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.9 | 2.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.9 | 7.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.9 | 3.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.9 | 7.3 | GO:0051525 | mitogen-activated protein kinase p38 binding(GO:0048273) NFAT protein binding(GO:0051525) |
0.9 | 18.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.9 | 1.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.9 | 3.5 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 7.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.9 | 6.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.9 | 2.6 | GO:0047522 | 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.9 | 5.1 | GO:0070728 | leucine binding(GO:0070728) |
0.8 | 20.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.8 | 4.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 3.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.8 | 13.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.8 | 27.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 6.9 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.8 | 19.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.8 | 7.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 2.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.7 | 17.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.7 | 2.1 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
0.7 | 18.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.7 | 6.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.7 | 10.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.7 | 2.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.7 | 5.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.7 | 2.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.7 | 4.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.7 | 6.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.7 | 21.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 3.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.7 | 3.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.7 | 7.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.6 | 2.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.6 | 557.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.6 | 3.0 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.6 | 1.8 | GO:0047708 | biotinidase activity(GO:0047708) |
0.6 | 10.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 5.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.6 | 3.5 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.6 | 7.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.6 | 6.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 8.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 3.9 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 10.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 67.4 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.5 | 3.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.5 | 1.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 14.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.5 | 37.8 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.5 | 24.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.5 | 12.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 19.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.5 | 5.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 2.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 22.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.5 | 3.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 1.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 3.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 3.6 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.4 | 1.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.4 | 3.5 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 2.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 2.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 2.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 2.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 7.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 7.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 13.9 | GO:0019842 | vitamin binding(GO:0019842) |
0.4 | 1.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 7.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 4.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.4 | 1.1 | GO:0017042 | glycosylceramidase activity(GO:0017042) |
0.3 | 2.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 4.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 8.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 6.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 4.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 4.9 | GO:0050661 | NADP binding(GO:0050661) |
0.3 | 17.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 12.9 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.3 | 5.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 3.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 2.0 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.3 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 2.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 2.8 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.3 | 4.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 2.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 5.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 2.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.8 | GO:0071209 | histone pre-mRNA DCP binding(GO:0071208) U7 snRNA binding(GO:0071209) |
0.3 | 2.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 2.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 2.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 2.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.2 | 0.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 1.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 3.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 2.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 4.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 16.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 1.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 6.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 4.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.2 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 6.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.7 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.2 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 4.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 1.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 15.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.3 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 11.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 2.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 9.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 2.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 3.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 4.3 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 4.9 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 4.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 3.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 1.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 16.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
0.1 | 0.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.6 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 1.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 2.5 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 1.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.8 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 1.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 8.9 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 5.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.6 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.3 | GO:0035375 | zymogen binding(GO:0035375) |
0.0 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0030626 | U12 snRNA binding(GO:0030626) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 136.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
3.6 | 195.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.7 | 34.8 | ST STAT3 PATHWAY | STAT3 Pathway |
2.3 | 13.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.7 | 407.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.6 | 41.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.6 | 83.8 | PID BMP PATHWAY | BMP receptor signaling |
1.2 | 26.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.2 | 52.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.1 | 41.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.1 | 30.3 | PID IGF1 PATHWAY | IGF1 pathway |
1.1 | 26.4 | PID ALK1 PATHWAY | ALK1 signaling events |
1.0 | 34.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.9 | 9.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.7 | 22.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 17.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.6 | 1.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.6 | 9.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 3.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 85.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 37.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 9.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 16.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 3.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 1.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 11.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 20.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 16.1 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 16.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 11.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 3.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 2.3 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 11.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 10.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 6.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 3.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 3.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 9.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 4.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 3.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 3.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 5.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.9 | 283.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
10.5 | 115.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
10.4 | 125.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
10.3 | 113.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
7.4 | 103.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
7.4 | 96.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
7.2 | 150.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
6.7 | 66.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
5.4 | 144.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
4.7 | 47.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
4.0 | 35.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.9 | 84.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
2.4 | 41.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.4 | 38.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
2.1 | 59.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
2.0 | 24.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.9 | 3.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.9 | 32.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.8 | 25.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.7 | 26.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.7 | 22.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.6 | 12.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.5 | 19.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.4 | 15.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.4 | 32.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.3 | 13.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.3 | 21.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
1.3 | 109.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.3 | 193.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.3 | 12.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.2 | 4.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.2 | 7.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.1 | 9.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.0 | 13.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.0 | 12.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 13.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.0 | 12.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.9 | 9.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.9 | 13.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.8 | 35.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.8 | 12.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.8 | 22.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.8 | 36.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 21.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.7 | 3.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.7 | 44.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.7 | 30.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 5.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.6 | 40.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 9.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 6.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 5.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.5 | 4.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 15.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 3.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 10.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 2.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 8.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 18.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.4 | 6.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 2.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 5.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 2.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 3.9 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 4.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 3.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 13.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 3.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 2.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 6.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 2.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 4.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 28.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 5.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 14.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 5.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 5.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 14.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 2.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 3.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 2.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |